Major Rating Factors:
Poor long-term capitalization index (0.1 on a scale of 0 to 10) based on weak current risk adjusted capital (severe and moderate loss scenarios). A history of deficient reserves (0.5) that places pressure on both capital and profits. In the last five years, reserves (two year development) fluctuated between 30.8% and 177.4% deficient. Weak profitability index (2.5) with operating losses during 2020, 2022, 2024 and the first three months of 2025. Average return on equity over the last five years has been poor at -12.4%.
Other Rating Factors:
Weak overall results on stability tests (0.8) including weak risk adjusted capital in prior years, weak results on operational trends and weak risk diversification. The largest net exposure for one risk is excessive at 22.0% of capital. Superior liquidity (10.0) with ample operational cash flow and liquid investments.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (100.0%)
Licensed in:
NV
Principal Investments:
Cash (30.9%), investment grade bonds (30.3%), common stock (20.6%), other (18.2%)
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
3651 Lindell Road
Las Vegas, NV 89103
Las Vegas, NV 89103
Phone Number
(855) 326-3408
NAIC Number
12988
Website
Largest Affiliates
No affiliate information available.